openPR Logo
Press release

At 8.9% of CAGR, Immunotherapy Drugs Market Size to Cross US$ 327.8 Billion by 2028 - IMARC Group

01-16-2023 06:49 AM CET | Health & Medicine

Press release from: IMARC Group

At 8.9% of CAGR, Immunotherapy Drugs Market Size to Cross US$

The latest research study "Immunotherapy Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" by IMARC Group, finds that the global immunotherapy drugs market size reached US$ 195.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 327.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.9% during 2023-2028.

Immunotherapy drugs represent specialized medications that are used for treating melanoma, lymphoma, sarcoma, and lung, bladder, kidney, and breast cancer. They usually target specific cells of the immune system and boost energy levels. In line with this, immunotherapy drugs stimulate the natural defenses of the body and help in fighting against allergies and infections caused by viruses and bacteria. They also assist in preventing the growth of cancer cells by triggering an immunological response that generates antibodies. Furthermore, immunotherapy drugs are effective in minimizing the complications of tumors and other chronic disorders. Consequently, they are gaining extensive traction across the globe.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request a free sample brochure: https://www.imarcgroup.com/immunotherapy-drugs-market/requestsample

Immunotherapy Drugs Market Trends and Drivers:

The expanding geriatric population and the elevating prevalence of tumor and target diseases are primarily driving the immunotherapy drugs market. Additionally, the rising occurrence of numerous genetic and lifestyle disorders and the increasing awareness among healthcare professionals and individuals towards the benefits of early diagnosis and treatment of cancer are further catalyzing the market growth. Besides this, the escalating demand for monoclonal antibodies and biosimilar drugs and the growing number of hospitals, pharmacies, and research laboratories are acting as significant growth-inducing factors. Moreover, key market players are focusing on strategic collaborations and new product developments to expand their product portfolio and gain a competitive edge, which is also positively influencing the global market. Apart from this, extensive investments in R&D activities by leading pharmaceutical and biotechnology companies to enhance the formulation of these medications are expected to fuel the immunotherapy drugs market over the forecasted period.

Inquire Before Buying: https://www.imarcgroup.com/request?type=report&id=6639&flag=F

Immunotherapy Drugs Market Report Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• AstraZeneca plc
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche AG
• GSK plc, Merck & Co. Inc.
• Pfizer Inc. and Sanofi S.A.

The report has been segmented the market into following categories:

Breakup by Type:
• Monoclonal Antibodies
• Vaccines
• Interferons Alpha and Beta
• Interleukins

Breakup by Therapy Area:
• Cancer
• Autoimmune and Inflammatory Diseases
• Infectious Diseases
• Others

Breakup by End User:
• Hospitals
• Clinics
• Others

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/immunotherapy-drugs-market

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Key highlights of the report:
• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Also Read:

https://www.marketwatch.com/press-release/atopic-dermatitis-market-size-2023-global-trends-industry-share-top-companies-and-report-by-2033-2023-01-10

https://www.marketwatch.com/press-release/urinary-retention-market-size-2023-trends-industry-share-top-companies-and-report-by-2033-2023-01-10

https://www.marketwatch.com/press-release/specialty-adhesives-market-size-2023-global-trends-industry-share-top-companies-and-report-by-2028-2023-01-10

https://www.marketwatch.com/press-release/ultra-mobile-device-market-report-2023-global-size-industry-share-trends-top-companies-and-forecast-by-2028-2023-01-10

https://www.marketwatch.com/press-release/automotive-thermoelectric-generator-market-report-2023-global-size-industry-share-trends-top-companies-and-forecast-by-2028-2023-01-10

https://www.marketwatch.com/press-release/high-throughput-satellite-market-report-2023-global-size-industry-share-trends-top-companies-and-forecast-by-2028-2023-01-10

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release At 8.9% of CAGR, Immunotherapy Drugs Market Size to Cross US$ 327.8 Billion by 2028 - IMARC Group here

News-ID: 2883926 • Views:

More Releases from IMARC Group

India Seafood Market Outlook 2025-2033: Key Trends, Size, Share and Growth Insights
India Seafood Market Outlook 2025-2033: Key Trends, Size, Share and Growth Insig …
As indicated in the latest market research report published by IMARC Group, titled "India Seafood Market Report by Type (Fish, Shrimps, Others), Form (Fresh/Chilled, Frozen/Canned, Processed), Distribution Channel (Off Trade, On Trade), and Region 2025-2033," this report provides an in-depth analysis of the industry, featuring insights into the market. It encompasses competitor and regional analyses, as well as recent advancements in the market. Market Size & Future Growth Potential: The India seafood
India Mutual Funds Market: Size, Share, Trends, Growth and Industry Outlook 2025-2033
India Mutual Funds Market: Size, Share, Trends, Growth and Industry Outlook 2025 …
Mutual Funds Market in India 2025: Base Year: 2024 Historical Years: 2019-2024 Forecast Years: 2025-2033 Market Size in 2024: USD 2.50 Billion Market Size in 2033: USD 5.90 Billion Market Growth Rate (CAGR) 2025-2033: 10.03% How Big is the India Mutual Funds Industry? The India mutual funds market size reached USD 2.50 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.90 Billion by 2033, exhibiting a growth rate (CAGR) of 10.03% during 2025-2033. Request
Dimethyl Ether Market Valuation to Reach USD 15.73 Billion by 2033 - Industry Expanding at a CAGR of 8.09%
Dimethyl Ether Market Valuation to Reach USD 15.73 Billion by 2033 - Industry Ex …
Market Overview: The dimethyl ether market is experiencing significant growth momentum, driven by increasing demand for cleaner fuel alternatives, expanding applications in various industries, and supportive government policies promoting sustainable energy solutions. According to IMARC Group's latest research publication, "Dimethyl Ether Market Size, Share, Trends and Forecast by Raw Material, Application, End-Use Industry, and Region, 2025-2033", the global dimethyl ether market size reached USD 7.22 Billion in 2024. Looking forward, IMARC
Glucometer Manufacturing Plant Report 2025: Unit Setup, Cost and Requirements, Project Economics
Glucometer Manufacturing Plant Report 2025: Unit Setup, Cost and Requirements, P …
Setting up a glucometer manufacturing plant requires thorough market research alongside a minute understanding of numerous operating factors such as unit processes, purchasing of raw materials, utility supply, infrastructure creation, equipment and technology specifications, human resource planning, logistics, and cash outlay. IMARC Group's report titled "Glucometer Manufacturing Plant Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a

All 5 Releases


More Releases for Immunotherapy

Immunotherapy Drugs Market
Immunotherapy Drugs Market Size reached US$ 288.02 Billion in 2024 and is expected to reach US$ 872.64 Billion by 2033, growing at a CAGR of 13.2% during the forecast period 2025-2033. The Immunotherapy Drugs Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead
Anti TIGIT Antibodies Revolutionizing Immunotherapy
Anti-TIGIT antibodies are at the forefront of a revolution in immunotherapy, representing a new class of immune checkpoint inhibitors that have the potential to transform the treatment landscape for cancer. Immunotherapy, which harnesses the body's immune system to fight cancer, has already made significant strides with the introduction of PD-1, PD-L1, and CTLA-4 inhibitors. However, the discovery and development of anti-TIGIT antibodies add a new dimension to this field, offering
Allergy Immunotherapy Market Combating the Rising Tide: The Allergy Immunotherap …
Allergy Immunotherapy Market is to reach over USD 4.01 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (SCIT, SLIT), By Allergy Type (Allergic Rhinitis, Asthma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Region, Market Outlook And Industry Analysis
Allergy Immunotherapy Market - Empowering Resilience, Defying Allergies: Advanci …
Newark, New Castle, USA - new report, titled Allergy Immunotherapy Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Allergy Immunotherapy market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Allergy Immunotherapy market. The report offers an overview of the market, which
Cancer Immunotherapy Market Cancer Immunotherapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Immunotherapy: Mending Cancer Regimens 1.1 Preface to Cancer Immunotherapy 1.2 Evolution of Cancer Immunotherapy 2. Categorization of Cancer Immunotherapy 2.1 Specific Cancer Immunotherapy 2.1.1 Cancer Vaccines 2.1.2 Monoclonal Antibodies 2.2 Non-Specific Cancer Immunotherapy 2.2.1 Adoptive Cell Transfer Immunotherapy 2.2.2 Immune Checkpoint Inhibitors 3. Fundamentals
Global Cancer Immunotherapy Market & Cancer Immunotherapy Clinical Trials Outloo …
Pharmaceutical companies are actively engaged in research and development of cancer immunotherapies because of large unmet medical necessities. Investigators are trying to come forth with innovative cancer immunotherapeutic products having high safety and efficacy profiles which are not offered by conventional therapeutics. Higher investments in research and development segment could significantly increase the drug discovery rates which will alleviate the medical condition of cancer patients. Simultaneously, technological advancements are being